ProTrials Research
ProTrials Research is a privately held, WBENC-certified woman-owned full-service clinical research organization (CRO) founded in 1996, serving pharmaceutical, biotechnology, and medical device sponsors with clinical operations, project management, data management, and decentralized trial services across six therapeutic areas.
- Company typePrivate
- Founded1996
- HeadquartersLos Gatos, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What ProTrials Research does
ProTrials Research, Inc. is a full-service clinical research organization (CRO) headquartered in Los Gatos, California, founded in 1996 as a 100% woman-owned business and currently operating under WBENC certification. The firm is led by Co-CEOs and co-founders Inger Arum and Jodi Andrews, with a Chief Revenue Officer (Matthew Smith) overseeing a sales-led go-to-market that acquires clients through a direct Request for Proposal (RFP) process targeting enterprise pharmaceutical, biotechnology, and medical device sponsors. Since inception, ProTrials has delivered more than 775 projects at over 17,500 sites with 210,000+ subjects enrolled, and currently employs between 101 and 250 people with clinical operations personnel deployed throughout North America and worldwide.
The company's offering is organized around seven core services — Project Management, Clinical Operations (monitoring and site management), Quality Assurance, Clinical Data Management, Medical and Regulatory Support, Functional Service Provider (FSP) staffing, and Early Phase studies — supplemented by a Virtual Trials and Remote Monitoring capability supporting decentralized and hybrid trial execution through eConsent, EDC, eISF, and HIPAA-compliant cloud environments. Therapeutic expertise spans Oncology, Ophthalmology, Central Nervous System, Infectious Disease, Women's Health, and Medical Device & Diagnostics, with the firm positioning itself as a flexible alternative to larger CROs through both full-service and FSP engagement models.
ProTrials generates revenue through professional services contracts for clinical research, with pricing not publicly disclosed and engagement terms set per RFP. The company has no disclosed funding rounds, no parent company, no institutional investors, and no M&A activity in the available data, operating as an independent private entity. Its competitive positioning rests on 25+ years of operating history, therapeutic breadth, WBENC-certified woman-owned status (relevant to sponsor supplier-diversity mandates), and a rescue-study capability that allows it to onboard mid-trial as a third-party CRO — evidenced by a Phase 3 renal cell carcinoma rescue engagement at 28 US sites for an unnamed global specialty pharmaceutical sponsor.
ProTrials Research firmographics
Firmographics- Name
- ProTrials Research
- Legal name
- ProTrials Research, Inc.
- Website
- https://protrials.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ProTrials Research is a privately held, WBENC-certified woman-owned full-service clinical research organization (CRO) founded in 1996, serving pharmaceutical, biotechnology, and medical device sponsors with clinical operations, project management, data management, and decentralized trial services across six therapeutic areas.
- Ownership category
- akta.pro rank
ProTrials Research industry classification
Industry- Product category
- Clinical Research Organization Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
Keywords
Where ProTrials Research is headquartered
LocationHeadquarters
- HQ city
- Los Gatos
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ProTrials Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- CRO Services Revenue: ProTrials generates revenue through providing comprehensive clinical research organization services including project management, clinical monitoring, data management, quality assurance, and regulatory support to pharmaceutical, biotechnology, and medical device companies across Phase I-IV clinical trials.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
ProTrials Research product offering
Product offeringCore offering
ProTrials Research is a full-service clinical research organization (CRO) that provides pharmaceutical, biotechnology, and medical device sponsors with site management, clinical monitoring, project management, clinical data management, quality assurance, and medical/regulatory support across Phase I–IV clinical trials. The company also delivers these capabilities through a Functional Service Provider (FSP) model and supports early-phase, virtual, and decentralized trials using enabling technology (eDC, eTMF, eConsent, remote monitoring). Therapeutic expertise is layered across oncology, ophthalmology, CNS, infectious disease, women's health, and medical device/diagnostics.
Product overview
ProTrials Research is a full-service clinical research organization (CRO) founded in 1996, headquartered in Los Gatos, California with operations throughout North America and worldwide. The company offers an integrated portfolio of clinical development services organized around core offerings: Project Management, Clinical Operations (monitoring and site management), Quality Assurance, Clinical Data Management, Medical and Regulatory Support, Functional Service Provider (FSP) solutions, and Early Phase services. The company provides specialized therapeutic expertise in Oncology, Ophthalmology, CNS, Infectious Disease, Women's Health, and Medical Device & Diagnostics. ProTrials also offers Virtual Trials and Remote Monitoring capabilities for decentralized trial execution. Since 1996, ProTrials has completed more than 775 projects at over 17,500 sites with 210,000+ subjects. The company operates as a WBENC-certified Women's Business Enterprise.
Differentiator
Problem solved
Functional benefit
Products and services
- Project Management Comprehensive project management services for clinical trials, including timeline management, resource allocation, and stakeholder coordination across all phases of research. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Clinical Operations Clinical monitoring and site management services ensuring proper execution of clinical trial protocols, subject safety, and data integrity at investigative sites. Targeted at pharmaceutical, biotechnology, and medical device sponsors running Phase I–IV trials.
- Quality Assurance Quality assurance auditing and compliance services to ensure clinical trials meet regulatory standards and ICH GCP guidelines. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Clinical Data Management Electronic Data Capture (EDC) platform management and clinical data management services for accurate collection, validation, and reporting of trial data. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Medical and Regulatory Support Medical monitoring, pharmacovigilance, regulatory affairs support, and safety reporting services including DSUR preparation, IND safety reports, and regulatory submissions. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Functional Service Provider (FSP) Flexible staffing solution providing specialized CRO resources including Clinical Research Associates (CRAs), project managers, biometrics services, and site management support on a scalable, on-demand basis. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Early Phase Services Early phase clinical research services including first-in-human studies, pharmacokinetics/pharmacodynamics, bioequivalence, dose escalation, and proof of concept studies. Targeted at pharmaceutical and biotechnology sponsors developing novel therapeutics.
- Virtual Trials and Remote Monitoring Decentralized clinical trial solutions offering fully virtual trials, hybrid trials with select virtual activities, and remote monitoring strategies to supplement on-site monitoring, enabled by telemedicine, eConsent, eDC, eISF, and HIPAA-compliant secure cloud environments. Targeted at pharmaceutical, biotechnology, and medical device sponsors.
- Oncology Therapeutic Services Clinical research services specializing in oncology trials including immunotherapy, cell therapy, and novel anticancer treatments across all trial phases. Targeted at oncology-focused pharmaceutical and biotechnology sponsors.
- Ophthalmology Therapeutic Services Specialized ophthalmology clinical trial services addressing conditions affecting the eye and vision. Targeted at pharmaceutical, biotechnology, and medical device sponsors developing ophthalmology products.
- Central Nervous System (CNS) Therapeutic Services Clinical research expertise in central nervous system disorders including neurological and psychiatric conditions. Targeted at pharmaceutical and biotechnology sponsors developing CNS therapies.
- Infectious Disease Therapeutic Services Clinical trial services for infectious disease research including vaccine development and antiviral therapies. Targeted at pharmaceutical and biotechnology sponsors developing infectious disease treatments.
- Women's Health Therapeutic Services Specialized clinical research services for women's health indications including reproductive health and gender-specific conditions. Targeted at pharmaceutical and biotechnology sponsors developing women's health therapies.
- Medical Device & Diagnostics Therapeutic Services Clinical trial management services for medical device and diagnostic product development across all regulatory pathways. Targeted at medical device and diagnostic companies.
Quantifiable outcome
- 775+ projects completed since 1996
- +2 more outcomes
Companies that use ProTrials Research
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
ProTrials Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ProTrials Research partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
ProTrials Research competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-size, therapeutically-focused full-service CRO with strong oncology and medical device capabilities serving small-to-mid biopharma sponsors. Closely comparable to ProTrials in service model, therapeutic focus, and customer base.
- Veristat: Mid-size CRO specializing in oncology, rare disease, and complex clinical development with biostatistics and clinical operations expertise. Comparable to ProTrials' therapeutically-focused, sponsor-segmented approach.
- Worldwide Clinical Trials: Mid-size full-service CRO with therapeutic expertise in CNS, oncology, and rare disease, offering FSP and full-service models. Comparable in service portfolio, therapeutic focus, and target customer base.
- Premier Research: Mid-size CRO providing full-service and FSP clinical research with focus on specialty therapeutics (oncology, rare disease, CNS, medical device). Direct competitor to ProTrials' positioning and service mix.
- Clinipace Worldwide: Mid-size CRO offering full-service clinical development and FSP solutions with therapeutic expertise across oncology and specialty areas. Comparable business model and customer segment to ProTrials.
- CTI Clinical Trial and Consulting Services: Mid-size CRO with therapeutic specialization in oncology, rare disease, and cell/gene therapy, offering full-service and FSP models. Comparable in size, therapeutic focus, and customer profile to ProTrials.
Broad incumbents
- IQVIA: Largest global CRO offering full-service clinical research, FSP, decentralized trials, and proprietary technology platforms. Competes with ProTrials on enterprise pharma RFPs but at vastly greater scale and broader portfolio.
- ICON plc: Global top-tier CRO with full-service clinical development, FSP, and labs. Overlaps with ProTrials in clinical operations and FSP offerings, but serves top-20 pharma at much larger scale.
- Syneos Health: Large CRO offering full-service clinical development and FSP across all phases and therapeutic areas. Competes with ProTrials in mid-tier and enterprise pharma segments at greater scale.
- Parexel International: Large global CRO with comprehensive clinical research, regulatory, and biopharma services. Overlaps with ProTrials' full-service and FSP offerings, including early phase and oncology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ProTrials Research social profiles
Digital presenceProTrials Research compliance and trust
Trust signalCompliance1 record
ProTrials Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProTrials Research leadership team
Management profileNumber of profiles
Profiles4 records
ProTrials Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProTrials Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProTrials Research
What does ProTrials Research do?
ProTrials Research is a full-service clinical research organization (CRO) that provides pharmaceutical, biotechnology, and medical device sponsors with site management, clinical monitoring, project management, clinical data management, quality assurance, and medical/regulatory support across Phase I–IV clinical trials. The company also delivers these capabilities through a Functional Service Provider (FSP) model and supports early-phase, virtual, and decentralized trials using enabling technology (eDC, eTMF, eConsent, remote monitoring). Therapeutic expertise is layered across oncology, ophthalmology, CNS, infectious disease, women's health, and medical device/diagnostics.
Is ProTrials Research a public or private company?
ProTrials Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ProTrials Research founded?
ProTrials Research was founded in 1996. It employs 101 to 250 people.
Where is ProTrials Research based?
ProTrials Research is headquartered in Los Gatos, United States, in the North America region.
How does ProTrials Research make money?
One revenue line is on record: CRO Services Revenue.
Who are ProTrials Research's main competitors?
Direct peers on record are Medpace, Veristat, Worldwide Clinical Trials, Premier Research, Clinipace Worldwide and CTI Clinical Trial and Consulting Services. Broad incumbents are IQVIA, ICON plc, Syneos Health and Parexel International.
Does ProTrials Research have an API?
No public API is recorded for ProTrials Research.
What industry is ProTrials Research in?
ProTrials Research's product category is Clinical Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.